Nonablative radiofrequency may improve sexual function in postmenopausal women
CLEVELAND, Ohio (Feb 11, 2026)—Hormone declines during menopause can cause genitourinary syndrome of menopause (GSM), a cluster of vulvovaginal and urinary symptoms that can significantly impair a woman’s quality of life. Local estrogen therapy is effective in relieving genitourinary symptoms, but a new study suggests nonablative capacitive-resistive monopolar radiofrequency (CRMRF) may also be effective in restoring vaginal and sexual health. Study results are published online today in Menopause, the journal of The Menopause Society.
Genitourinary syndrome of menopause is estimated to affect at least half of postmenopausal women. Common symptoms include ...